数字聚合酶链反应
病毒载量
实时聚合酶链反应
医学
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
内科学
金标准(测试)
2019年冠状病毒病(COVID-19)
喉部
病毒学
胃肠病学
聚合酶链反应
病毒
外科
生物
疾病
传染病(医学专业)
基因
生物化学
作者
Tao Suo,Xinjin Liu,Jiangpeng Feng,Ming Guo,Wenjia Hu,Dong Guo,Hafiz Ullah,Yang Yang,Qiuhan Zhang,Xin Wang,Muhammad Sajid,Zhixiang Huang,Liping Deng,Tielong Chen,Fang Liu,Ke Xu,Yuan Liu,Zhang Qi,Yingle Liu,Yong Xiong,Guozhong Chen,Ke Lan,Yu Chen
出处
期刊:Cold Spring Harbor Laboratory - medRxiv
日期:2020-03-06
被引量:48
标识
DOI:10.1101/2020.02.29.20029439
摘要
Abstract Real time fluorescent quantitative PCR (RT-PCR) is widely used as the gold standard for clinical detection of SARS-CoV-2. However, due to the low viral load in patient throats and the limitations of RT-PCR, significant numbers of false negative reports are inevitable, which results in failure to timely diagnose, early treat, cut off transmission, and assess discharge criteria. To improve this situation, an optimized droplet digital PCR (ddPCR) was used for detection of SARS-CoV-2, which showed that the limit of detection of ddPCR is significantly lower than that of RT-PCR. We further explored the feasibility of ddPCR to detect SARS-CoV-2 nucleic acid from 77 clinical throat swab samples, including 63 suspected outpatients with fever and 14 supposed convalescents who were about to discharge after treatment, and compared with RT-PCR in terms of the diagnostic accuracy. In this double-blind study, we tested, surveyed subsequently and statistically analyzed 77 clinical samples. According to our study, 26 samples from COVID-19 patients with RT-PCR negative were detected as positive by ddPCR. No FPRs of RT-PCR and ddPCR were observed. The sensitivity, specificity, PPV, NPV, NLR and accuracy were improved from 40% (95% CI: 27–55%), 100% (95% CI: 54–100%), 100%, 16% (95% CI: 13–19%), 0.6 (95% CI: 0.48–0.75) and 47% (95% CI: 33–60%) for RT-PCR to 94% (95% CI: 83–99%), 100% (95% CI: 48–100%), 100%, 63% (95% CI: 36–83%), 0.06 (95% CI: 0.02–0.18) and 95% (95% CI: 84–99%) for ddPCR, respectively. Moreover, 14 (42.9 %) convalescents still carry detectable SARS-CoV-2 after discharge. Overall, ddPCR shows superiority for clinical diagnosis of SARS-CoV-2 to reduce the false negative reports, which could be a powerful complement to the current standard RT-PCR. It also suggests that the current clinical practice that the convalescent after discharge continues to be quarantined for at least 2 weeks is completely necessary which can prevent potential viral transmission.